ReEmerge raises $37M
ReEmerge announced a Series A round of $37M on 15 September 2026. The company operates in HealthTech and is based in United States. It was founded by Todd Langevin, CEO. Announced 3 days ago.
Founder
Todd Langevin
CEO, ReEmerge
Outreach angles
- -Todd Langevin leads ReEmerge as CEO, working alongside physician-scientist co-founder Dr. Nicholas Schiff of Weill Cornell Medicine.
- -The company's technology builds on Schiff's research published in Nature Medicine on neural stimulation for brain injury.
- -The oversubscribed $37M Series A will fund a multicenter clinical study enrolling up to 40 patients with chronic traumatic brain injury.
Signals
Series AHealthcareDeep TechB2BRegulated Industry
Round details
Company: ReEmerge
Domain: reemergeinc.com
Amount: $37M
Stage: Series A
Industry: HealthTech
Country: United States
Announced: 15 September 2026
Other HealthTech raises
Recently funded in United States